首页出版说明中文期刊中文图书环宇英文官网付款页面

儿童癫痫药物治疗现状分析

何 金月, 张静 通讯
华北理工大学

摘要


摘要:目的:癫痫是儿童神经系统常见慢性疾病,严重影响患儿生长发育及日常生活,给其家庭及社会带来巨大压力。目前治疗儿童癫痫仍以抗癫痫
药物治疗为主,早期选择合适药物有效控制患儿癫痫发作至关重要,本文就目前儿童癫痫常用药物从其机制、疗效及安全性方面做一阐述,以
期为临床治疗提供一定参考。

关键词


关键词:儿童癫痫、抗癫痫发作药物 治疗

全文:

PDF


参考


[1]VOSSLER D G, WEINGARTEN M, GIDAL B E. Summary of

Antiepileptic Drugs Available in the United States of America:

WORKING TOWARD A WORLD WITHOUT EPILEPSY [J]. Epilepsy

currents, 2018, 18(4 Suppl 1): 1-26.

药物与临床

76

医学研究

[2]WANG Y, CHEN Y B, ZHANG Y Q, et al. Oxcarbazepine oral

suspension in pediatric patients with partial seizures and/or generalized

tonic-clonic seizures: a multi-center, single arm, observational study in

China [J]. World journal of pediatrics : WJP, 2017, 13(6): 551-9.

[3]SUO G H, ZHENG Y Q, WU Y J, et al. Effects of levetiracetam

and oxcarbazepine monotherapy on intellectual and cognitive

development in children with benign epilepsy with centrotemporal spikes

[J]. Acta neurologica Belgica, 2021, 121(5): 1265-73.

[4]GENG H, WANG C. Efficacy and safety of oxcarbazepine in the

treatment of children with epilepsy: a meta-analysis of randomized

controlled trials [J]. Neuropsychiatric disease and treatment, 2017,

13(685-95.

[5]JOHANNESSEN C U, JOHANNESSEN S I. Valproate: past,

present, and future [J]. CNS drug reviews, 2003, 9(2): 199-216.

[6]GUERRINI R, GENTON P. Epileptic syndromes and visually

induced seizures [J]. Epilepsia, 2004, 45 Suppl 1(14-8.

[7]NANAU R M, NEUMAN M G. Adverse drug reactions induced

by valproic acid [J]. Clinical biochemistry, 2013, 46(15): 1323-38.

[8]WU T, IDO K, OHGOH M, et al. Mode of seizure inhibition by

sodium channel blockers, an SV2A ligand, and an AMPA receptor

antagonist in a rat amygdala kindling model [J]. Epilepsy research, 2019,

154(42-9.

[9]ABDELMESIH S K, ELKHATEEB N, ZAKARIA M, et al. Initial

levetiracetam versus valproate monotherapy in antiseizure medicine

(ASM)-naïve pediatric patients with idiopathic generalized epilepsy with

tonic-clonic seizures [J]. Seizure, 2021, 91(263-70.

[10]FALSAPERLA R, SCALIA B, GIUGNO A, et al. Treating the

symptom or treating the disease in neonatal seizures: a systematic review

of the literature [J]. Italian journal of pediatrics, 2021, 47(1): 85.

[11]ARICAN P, GENCPINAR P, CAVUSOGLU D, et al.

Levetiracetam monotherapy for the treatment of infants with epilepsy [J].

Seizure, 2018, 56(73-7.

[12]WILSON S M, KHANNA R. Specific binding of lacosamide to

collapsin response mediator protein 2 (CRMP2) and direct impairment of

its canonical function: implications for the therapeutic potential of

lacosamide [J]. Molecular neurobiology, 2015, 51(2): 599-609.

[13]FARKAS V, STEINBORN B, FLAMINI J R, et al. Efficacy and

tolerability of adjunctive lacosamide in pediatric patients with focal

seizures [J]. Neurology, 2019, 93(12): e1212-e26.

[14]LI K Y, HUANG L C, CHANG Y P, et al. The effects of

lacosamide on cognitive function and psychiatric profiles in patients with

epilepsy [J]. Epilepsy & behavior : E&B, 2020, 113(107580.

[15]GUL A, MEHREEN S. Effectiveness of Lacosamide on everyday

cognitive deficits, psychiatric symptoms and resilience in patients with

epilepsy [J]. JPMA The Journal of the Pakistan Medical Association,

2020, 70(9): 1611-5.

第一作者:何金月 女 回族 1997 年 10 月 安徽滁州 研究生

通讯作者:张静 女 汉族 1980 年 10 月 河北唐山 研究生




DOI: http://dx.doi.org/10.12361/2661-3603-05-16-144100

Refbacks

  • 当前没有refback。